Celldex (CLDX) – Analyst EPS View
-
Celldex Therapeutics (CLDX) PT Lowered to $3.50 at Jefferies
-
Celldex Therapeutics (CLDX) PT Lowered to $4 at Jefferies; Phase 3 METRIC Data Expected in 2018
-
-
-
-
-
-
-
-
-
-
-
-
Back to CLDX Stock Lookup